Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial
American Journal of Ophthalmology Jan 13, 2018
Buitendijk GHS, et al. - Experts coveted an assessment of the upshot of antiplatelet or anticoagulant (AP/AC) medication use on the visual acuity of patients with active neovascular age-related macular degeneration (N-AMD). They did not discover any connection between the use of AP/AC medication with a visual decline and with the occurrence of hemorrhages in the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
